Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis

Authors

  • Jan F. Silverman M.D.,

    Corresponding author
    1. Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC; Department of Pathology, University of Florida Health Science Center, Jacksonville, FL; Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and the Department of Pathology, Cytology Division, University of Texas M. D. Anderson Cancer Center, Houston, TX
    • Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC 27858-4354
    Search for more papers by this author
  • Shahla Masood M.D.,

    1. Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC; Department of Pathology, University of Florida Health Science Center, Jacksonville, FL; Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and the Department of Pathology, Cytology Division, University of Texas M. D. Anderson Cancer Center, Houston, TX
    Search for more papers by this author
  • Dr. Barbara S. Ducatman M.D.,

    1. Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC; Department of Pathology, University of Florida Health Science Center, Jacksonville, FL; Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and the Department of Pathology, Cytology Division, University of Texas M. D. Anderson Cancer Center, Houston, TX
    Current affiliation:
    1. Pathology Section, Laboratory Investigations Branch, NIOSH-ALOSH, Morgantown, WV.
    Search for more papers by this author
  • Helen H. Wang M.D., Dr.P.H.,

    1. Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC; Department of Pathology, University of Florida Health Science Center, Jacksonville, FL; Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and the Department of Pathology, Cytology Division, University of Texas M. D. Anderson Cancer Center, Houston, TX
    Search for more papers by this author
  • Nour Sneige M.D.

    1. Department of Pathology and Laboratory Medicine, East Carolina University School of Medicine, Greenville, NC; Department of Pathology, University of Florida Health Science Center, Jacksonville, FL; Department of Pathology, Beth Israel Hospital and Harvard Medical School, Boston, MA; and the Department of Pathology, Cytology Division, University of Texas M. D. Anderson Cancer Center, Houston, TX
    Search for more papers by this author

Ancillary